Results 71 to 80 of about 10,800,546 (271)
Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky +5 more
wiley +1 more source
Impact of inflammation on extinction of pain-related fear
Da akute Entzündung Auswirkungen auf Emotionen, Kognitionen und Schmerzwahrnehmung hat, liegt ein Einfluss auf Lern- und Gedächtnisprozesse im Kontext von Schmerzen nahe. Um das zu testen, wurden gesunde Probanden randomisiert und erhielten Endotoxin oder Placebo vor der Akquisition oder der Extinktion schmerzbezogener Furcht.
openaire +2 more sources
Comorbidity of pain and posttraumatic stress disorder is well recognized, but the reason for this association is unclear. This study investigated the direction of the relationship between pain and traumatic stress and the role that pain-related fear ...
Adele Eather +10 more
core +1 more source
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali +4 more
wiley +1 more source
Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son +3 more
wiley +1 more source
BackgroundChronic low back pain (cLBP) can interfere with daily activities, and individuals with elevated pain-related fear (also known as kinesiophobia or the fear of injury due to movement) can develop worse long-term disability. Graded exposure (GEXP)
Hennessy, Rebecca White +4 more
doaj +1 more source
Expectancy, fear and pain in the prediction of chronic pain and disability : A prospective analysis
Studies with (sub) acute back pain patients show that negative expectancies predict pain and disability at a one-year follow up. Yet, it is not clear how expectations relate to other factors in the development of chronic disability such as pain and fear.
Linton, Steven J.,, Boersma, Katja,
core +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Can Pain-Related Fear Be Reduced? The Application of Cognitive-Behavioural Exposure in Vivo
Although cognitive-behavioural treatments of patients with chronic pain generally are reported to be effective, customization might increase their effectiveness.
Johan WS Vlaeyen +4 more
doaj +1 more source
Fear avoidance beliefs in back pain-free subjects are reflected by amygdala-cingulate responses
In most individuals suffering from chronic low back pain, psychosocial factors, specifically fear avoidance beliefs, play central roles in the absence of identifiable organic pathology.
Michael Lukas Meier +7 more
doaj +1 more source

